FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November (BATS:XNOV) Sees Significant Increase in Short Interest

FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November (BATS:XNOV) was the target of a large increase in short interest in May. As of May 29th, there was short interest totaling 4,039 shares, an increase of 107.7% from the May 14th total of 1,945 shares. Based on an average daily volume of 301 shares, the short-interest ratio is presently 13.4 days. Currently, 0.5% of the shares of the company are sold short.

FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November Trading Up 0.1%

FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November stock opened at $39.39 on Friday. FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November has a 12 month low of $34.89 and a 12 month high of $39.49. The stock’s 50 day simple moving average is $38.93 and its two-hundred day simple moving average is $38.22. The firm has a market cap of $29.54 million, a PE ratio of 24.94 and a beta of 0.24.

Institutional Investors Weigh In On FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November

A hedge fund recently bought a new stake in FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November stock. Arkadios Wealth Advisors acquired a new position in FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November (BATS:XNOV) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 8,548 shares of the company’s stock, valued at approximately $324,000. Arkadios Wealth Advisors owned approximately 1.42% of FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November at the end of the most recent quarter.

About FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November

The FT Vest U.S. Equity Enhance & Moderate Buffer ETF – November (XNOV) is an exchange-traded fund that mostly invests in large cap equity. The fund seeks to outperform the SPY ETF at about 2x positive price returns while aiming for specific buffered losses and capped gains over a one-year period. The actively managed fund holds options and collateral. XNOV was launched on Nov 17, 2023 and is issued by First Trust.